4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-25-303910
Chief Operating Officer sold 5,000 shares at $30.10 ($150,487)
- Chief Operating Officer acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gault Cheryl Chief Operating Officer | 2025-11-26 | Option exercise 10b5-1 | +5,000 | $1.80 | $9,000 | 176,928 | D: show line 1 in the form |
| Gault Cheryl Chief Operating Officer | 2025-11-26 | Sale 10b5-1 | −5,000 | $30.10 | $150,487 | 171,928 | D: show line 2 in the form |
| Open-market sales · 5,000 sh · avg $30.10 · $150,487 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gault Cheryl Chief Operating Officer | 2025-11-26 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 105,407 | D: show line 3 in the form |
Loading xslF345X05/ownership.xml…